Prostaglandin EP4 receptor enhances BCR-induced apoptosis of immature B cells

Prostaglandins and Other Lipid Mediators

Volumn 95, Issue 1-4, 2011, Pages 19-26

  Prijatelj, Matevz ^a   Celhar, Teja ^a   Mlinaric Rascan, Irena ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Apoptosis; B cell receptor; EP4 receptor; Immature B cell; NF B; PGE2

Indexed keywords

B LYMPHOCYTE RECEPTOR; CASPASE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONO AE3 208; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL SURVIVAL; GENE EXPRESSION; MOUSE; NONHUMAN; PRE B LYMPHOCYTE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; DINOPROSTONE; GENE EXPRESSION; INTERPHASE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NAPHTHALENES; NF-KAPPA B; PHENYLBUTYRATES; PRE-B CELL RECEPTORS; PRECURSOR CELLS, B-LYMPHOID; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE;

EID: 79960842624     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2011.04.001     Document Type: Article

References (38)

1. T. Kurosaki Genetic analysis of B cell antigen receptor signaling Annu Rev Immunol 17 1999 555 592 (Pubitemid 29241134)
2. J.G. Monroe Molecular mechanisms regulating B cell negative selection Biochem Soc Trans 25 1997 643 647 (Pubitemid 27260888)
3. I. Mlinaric-Rascan, and B. Turk B cell receptor-mediated nuclear fragmentation proceeds in WEHI 231 cells in the absence of detectable DEVDase and FRase activity FEBS Lett 553 2003 51 55 (Pubitemid 37206323)
4. J. Eeva, and J. Pelkonen Mechanisms of B cell receptor induced apoptosis Apoptosis 9 2004 525 531 (Pubitemid 39158628)
5. H. Niiro, and E.A. Clark Regulation of B cell fate by antigen receptor signals Nat Rev Immunol 2 2002 945 956 (Pubitemid 37323215)
6. A. Keutgens, I. Robert, P. Viatour, and A. Chariot Deregulated NF-κB activity in haematological malignancies Biochem Pharmacol 72 2006 1069 1080 (Pubitemid 44479739)
7. S.G. Harris, J. Padilla, L. Koumas, D. Ray, and R.P. Phipps Prostaglandins as modulators of immunity Trends Immunol 23 2002 144 150 (Pubitemid 34178297)
8. J.I. Kurland, P.W. Kincade, and M.A. Moore Regulation of B-lymphocyte clonal proliferation by stimulatory and inhibitory macrophage derived factors J Exp Med 46 1977 1420 1435 (Pubitemid 8218420)
9. D.M. Brown, G.L. Warner, J.E. Alés-Martínez, D.W. Scott, and R.P. Phipps Prostaglandin E2 induces apoptosis in immature normal and malignant B lymphocytes Clin Immunol Immunopathol 63 1992 221 229
10. R.L. Roper, and R.P. Phipps Prostaglandin E2 and cAMP inhibit B lymphocyte activation and simultaneously promote IgE and IgG1 synthesis J Immunol 49 1992 2984 2991
11. R.P. Phipps, D. Lee, V. Schad, and G.L. Warner E-series prostaglandins are potent growth inhibitors for some B lymphomas Eur J Immunol 19 1989 995 1000
12. S. Narumiya, Y. Sugimoto, and F. Ushikubi Prostanoid receptors: structures properties, and functions Physiol Rev 79 1999 1193 1226 (Pubitemid 29473315)
13. J. Murn, I. Mlinaric-Rascan, P. Vaigot, O. Alibert, V. Frouin, and X. Gidrol A Myc-regulated transcriptional network controls B-cell fate in response to BCR triggering BMC Genomics 10 2009 323
14. J. Murn, O. Alibert, N. Wu, S. Tendil, and X. Gidrol Prostaglandin E2 regulates B cell proliferation through a candidate tumor suppressor, Ptger4 J Exp Med 205 2008 3091 3103
15. H. Fujino, S. Salvi, and J.W. Regan Differential regulation of phosphorylation of the cAMP response element-binding protein after activation of EP2 and EP4 prostanoid receptors by prostaglandin E2 Mol Pharmacol 68 2005 251 259 (Pubitemid 41002965)
16. K. Fushimi, S. Nakashima, F. You, M. Takigawa, and K. Shimizu Prostaglandin E2 downregulates TNF-alfa-induced production of matrix metalloproteinase-1 in HCS-2/8 chondrocytes by inhibiting Raf-1/MEK/ERK cascade through EP4 prostanoid receptor activation J Cell Biochem 100 2007 783 793 (Pubitemid 46180539)
17. M. Minami, K. Shimizu, and Y. Okamoto Prostaglandin E receptor type 4-associated protein interacts directly with NF-κB1 and attenuates macrophage activation J Biol Chem 283 2008 9692 9703
18. M. Milek, N. Karas Kuzelicki, A. Smid, and I. Mlinaric-Rascan S-adenosylmethionine regulates thiopurine methyltransferase activity and decreases 6-mercaptopurine cytotoxicity in MOLT lymphoblasts Biochem Pharmacol 77 2009 1845 1853
19. A. Avramidou, C. Kroczek, C. Lang, W. Schuh, H.M. Jäck, and D. Mielenz The novel adaptor protein Swiprosin-1 enhances BCR signals and contributes to BCR-induced apoptosis Cell Death Differ 14 2007 1936 1947 (Pubitemid 350011669)
20. J.P. Smith, G.F. Burton, J.G. Tew, and A.K. Szakal Tangible body macrophages in regulation of germinal center reactions Dev Immunol 6 1998 285 294 (Pubitemid 28517785)
21. T. Shimozato, and P.W. Kincade Prostaglandin E2 and stem cell factor can deliver opposing signals to B lymphocyte precursors Cell Immunol 198 1999 21 29 (Pubitemid 30044153)
22. N. Nishigaki, M. Negishi, and A. Honda Identification of prostaglandin E receptor 'EP2' cloned from mastocytoma cells EP4 subtype FEBS Lett 364 1995 339 341
23. Y. Sugimoto, and S. Narumija Prostaglandin E receptors J Biol Chem 282 2007 11613 11617 (Pubitemid 47100657)
24. D.M. Brown, and R.P. Phipps Characterization and regulation of prostaglandin E2 receptors on normal and malignant murine B lymphocytes Cell Immunol 161 1995 79 87
25. J.G. Monroe B-cell antigen receptor signaling in immature-stage B cells: integrating intrinsic and extrinsic signals Curr Top Microbiol Immunol 245 2000 1 29
26. L.B. King, A. Norvell, and J.G. Monroe Antigen receptor-induced signal transduction imbalances associated with the negative selection of immature B cells J Immunol 162 1999 2655 2662 (Pubitemid 29309286)
27. B. Feng, S. Cheng, C.Y. Hsia, L.B. King, J.G. Monroe, and H.C. Liou NF-κB inducible genes BCL-X and cyclin E promote immature B-cell proliferation and survival Cell Immunol 232 2004 9 20 (Pubitemid 40732716)
28. D. Kovesdi, K. Paszty, and A. Enyedi Antigen receptor-mediated signaling pathways in transitional immature B cells Cell Signal 16 2004 881 889 (Pubitemid 38638778)
29. H.C. Liou, and C.Y. Hsia Distinctions between c-Rel and other NF-κB proteins in immunity and disease Bioessays 25 2003 767 780 (Pubitemid 36966377)
30. M. Grossmann, Y. Nakamura, R. Grumont, and S. Gerondakis New insights into the roles of ReL/NF-κB transcription factors in immune function, hemopoiesis and human disease Int J Biochem Cell Biol 31 1999 1209 1219 (Pubitemid 29454555)
31. A.M. Owyang, J.R. Tumang, and B.R. Schram c-Rel is required for the protection of B cells from antigen receptor-mediated, but not Fas-mediated, apoptosis J Immunol 167 2001 4948 4956 (Pubitemid 33009725)
32. J.R. Tumang, A. Owyang, and S. Andjelic c-Rel is essential for B lymphocyte survival and cell cycle progression Eur J Immunol 28 1998 4299 4312 (Pubitemid 28558661)
33. J. Schulze-Luehrmann, and S. Ghosh Antigen-receptor signaling to nuclear factor κB Immunity 25 2006 701 715
34. H. Sheng, J. Shao, M.K. Washington, and R.N. DuBois Prostaglandin E2 increases growth and motility of colorectal carcinoma cells J Biol Chem 276 2001 18075 18081
35. A. Pozzi, X. Yan, and I. Macias-Perez Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation J Biol Chem 279 2004 29797 29804 (Pubitemid 38915863)
36. S. Desai, and B. Ashby Agonist-induced internalization and mitogen-activated protein kinase activation of the human prostaglandin EP4 receptor FEBS Lett 501 2001 156 160
37. H. Gao, Y. Sun, and Y. Wu Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-κB pathways Mol Cell 14 2004 303 317 (Pubitemid 38591402)
38. D.S. Witherow, T.R. Garrison, W.E. Miller, and R.J. Lefkowitz Beta-Arrestin inhibits NF-κB activity by means of its interaction with the NF-κB inhibitor IκBα Proc Natl Acad Sci U S A 101 2004 8603 8607 (Pubitemid 38745817)